Adjunctive rosiglitazone treatment for severe pediatric malaria: A randomized placebo-controlled trial in Mozambican children
Open Access
- 26 November 2023
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 139, 34-40
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malariaCritical Care Medicine, 2012
- Combinations of Host Biomarkers Predict Mortality among Ugandan Children with Severe Malaria: A Retrospective Case-Control StudyPLOS ONE, 2011
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malariaMalaria Journal, 2009
- Use of Peroxisome Proliferator‐Activated Receptor γ Agonists as Adjunctive Treatment forPlasmodium falciparumMalaria: A Randomized, Double‐Blind, Placebo‐Controlled TrialClinical Infectious Diseases, 2009
- Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African ChildrenPLOS ONE, 2009
- Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malariaProceedings of the National Academy of Sciences, 2008
- Malaria in rural Mozambique. Part II: children admitted to hospitalMalaria Journal, 2008
- The Many Faces of PPARγCell, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005